×

Our Best Shot - CHI’s Mandatory COVID-19 Vaccination Policy

CHI has instituted a mandatory vaccination policy for all in-person participants across all our events. Learn more about our health and safety protocols.

TRI-CON 2022: 
Driving Innovation and Collaboration
in Diagnostics and Precision Medicine

Over the past 28 years, the Tri-Conference has served as the leading international meeting place for the precision medicine community. As the world faces the challenges from the pandemic recovery, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2022. Join thousands of international thought leaders —in-person and/or virtually— to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis. Come to sunny San Diego for the in-person networking you’ve come to expect from the Tri-Conference; or join us virtually from the comfort of your home or office for online networking, the cutting-edge scientific program, and convenient on-demand viewing.





Featured Speakers

Steven Schachter

Steven Schachter
RADx Chief; Professor
Harvard Medical School

Lisa Suennen

Lisa Suennen
Lead, Digital & Technology Group
Manatt Ventures

Sir Mark Caulfield

Sir Mark Caulfield
CEO
Barts Life Sciences

Jessica L. Mega

Jessica L. Mega
Co-Founder & CSO
Verily

Robert C. Green

Robert C. Green
Director, G2P Program
Brigham and Women's Hospital

Cecilia Schott

Cecilia Schott
Head, Global Precision Medicine
Novartis

Simon Gregory

Simon Gregory
Director, Molecular Genomics Core
Duke Molecular Physiology Institute

Ruth March

Ruth March
SVP & Head, Precision Medicine
AstraZeneca

Howard I. Scher

Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Mara Aspinall

Mara Aspinall
Managing Director
BlueStone Venture Partners

Tom Miller

Tom Miller
Founder, Managing Partner
GreyBird Ventures

Lara Jehi

Lara Jehi
Chief Research Information Officer
Cleveland Clinic

Vincent Mikol

Vincent Mikol
Head, Translational Sciences,
Sanofi

Megan Mahoney

Megan Mahoney
Chief of Staff
Stanford Health Care

Michael Snyder

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford Univ

Esther Babady

Esther Babady
Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Jürgen Scheuenpflug

Jürgen Scheuenpflug
Global Head, Biomarkers and Companion Diagnostics
Merck

Ellie Corigliano

Ellie Corigliano
Head, Precision Medicine and Diagnostics
GlaxoSmithKline

Dan Theodorescu

Dan Theodorescu
Director
Cedars-Sinai Cancer Center

Razelle Kurzrock

Razelle Kurzrock
Chair
Worldwide Innovative Network (WIN) for Personalized Cancer Therapy

Nathan D. Price

Nathan D. Price
CEO
Onegevity

Shirin Khambata Ford

Shirin Khambata Ford
Head, Precision Medicine
Daiichi Sankyo

Adam Dakin

Adam Dakin
Managing Director, Healthtech
Dreamit Ventures

Pia Davidsson

Pia Davidsson
Head, Experimental Medicine
AstraZeneca

John Quackenbush

John Quackenbush
Chair, Biostatistics
Harvard


Sights and Scenes from previous TRI-CONs




Premier Sponsors






Key Contacts

Jon Stroup

For partnering & sponsorship, please contact:
Jon Stroup
Sr. Business Development Manager
Cambridge Healthtech Institute
781-972-5483 jstroup@healthtech.com

Julia Boguslavsky

For meeting questions or suggestions, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

Jennifer Salhus

For media and association partnerships, please contact:
Rich Handy
Senior Director of Marketing
Cambridge Healthtech Institute
781-972-5456
rhandy@healthtech.com